Literature DB >> 17060447

Structural basis for inhibition of translation by the tumor suppressor Pdcd4.

Nicole LaRonde-LeBlanc1, Arti N Santhanam, Alyson R Baker, Alexander Wlodawer, Nancy H Colburn.   

Abstract

The tumor suppressor function of Programmed Cell Death 4 (Pdcd4) is achieved through interactions between Pdcd4 and components of the translation initiation complex, namely, the RNA helicase eIF4A and the scaffolding protein eIF4G. These interactions are mediated through two MA3 domains on the Pdcd4 molecule and result in inhibition of protein synthesis. We have solved the high-resolution crystal structure of the C-terminal MA3 (cMA3) domain of Pdcd4 in several crystal forms and demonstrated its similarity to the MA3 domain of eIF4G. As predicted by the structure, the cMA3 domain competes with eIF4Gc for binding to eIF4A and surprisingly is sufficient to inhibit translation initiation. Mutations that abolish eIF4A binding negate both functions of the cMA3. Interestingly mutations in the Akt phosphorylation site influenced neither cMA3 binding to eIF4A nor its ability to inhibit translation initiation. Finally, our structural analysis reveals MA3 domains to be a novel subfamily of VHS domains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060447      PMCID: PMC1800662          DOI: 10.1128/MCB.00867-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Novel eIF4G domain homologues linking mRNA translation with nonsense-mediated mRNA decay.

Authors:  C P Ponting
Journal:  Trends Biochem Sci       Date:  2000-09       Impact factor: 13.807

3.  The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.

Authors:  Hsin-Sheng Yang; Aaron P Jansen; Anton A Komar; Xiaojing Zheng; William C Merrick; Sylvain Costes; Stephen J Lockett; Nahum Sonenberg; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

4.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation.

Authors:  J L Cmarik; H Min; G Hegamyer; S Zhan; M Kulesz-Martin; H Yoshinaga; S Matsuhashi; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death.

Authors:  K Shibahara; M Asano; Y Ishida; T Aoki; T Koike; T Honjo
Journal:  Gene       Date:  1995-12-12       Impact factor: 3.688

6.  Structure of the VHS domain of human Tom1 (target of myb 1): insights into interactions with proteins and membranes.

Authors:  S Misra; B M Beach; J H Hurley
Journal:  Biochemistry       Date:  2000-09-19       Impact factor: 3.162

7.  Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.

Authors:  Alexey Palamarchuk; Alexey Efanov; Vadim Maximov; Rami I Aqeilan; Carlo M Croce; Yuri Pekarsky
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

8.  Interaction between the NH2-terminal domain of eIF4A and the central domain of eIF4G modulates RNA-stimulated ATPase activity.

Authors:  Nadia L Korneeva; Eric A First; Clint A Benoit; Robert E Rhoads
Journal:  J Biol Chem       Date:  2004-11-04       Impact factor: 5.157

9.  Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.

Authors:  Aaron P Jansen; Corinne E Camalier; Nancy H Colburn
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

10.  Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity.

Authors:  Aaron P Jansen; Corinne E Camalier; Cristi Stark; Nancy H Colburn
Journal:  Mol Cancer Ther       Date:  2004-02       Impact factor: 6.261

View more
  37 in total

1.  Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.

Authors:  Arti B Gaur; Susan L Holbeck; Nancy H Colburn; Mark A Israel
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

Review 2.  Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue?

Authors:  Matthew R Young; Arti N Santhanam; Noriko Yoshikawa; Nancy H Colburn
Journal:  Mol Interv       Date:  2010-04

Review 3.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

4.  Crystal structure of the eIF4A-PDCD4 complex.

Authors:  Jeong Ho Chang; Yong Hyun Cho; Sun Young Sohn; Jung Min Choi; Ahreum Kim; Young Chang Kim; Sung Key Jang; Yunje Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

5.  Enhanced arginine methylation of programmed cell death 4 protein during nutrient deprivation promotes tumor cell viability.

Authors:  Marta M Fay; James M Clegg; Kimberly A Uchida; Matthew A Powers; Katharine S Ullman
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

6.  Development of a high-throughput cell-based reporter assay to identify stabilizers of tumor suppressor Pdcd4.

Authors:  Johanna S Blees; Tobias Schmid; Cheryl L Thomas; Alyson R Baker; Lauren Benson; Jason R Evans; Ekaterina I Goncharova; Nancy H Colburn; James B McMahon; Curtis J Henrich
Journal:  J Biomol Screen       Date:  2009-11-09

7.  Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma.

Authors:  Patricia P Reis; Miranda Tomenson; Nilva K Cervigne; Jerry Machado; Igor Jurisica; Melania Pintilie; Mahadeo A Sukhai; Bayardo Perez-Ordonez; Reidar Grénman; Ralph W Gilbert; Patrick J Gullane; Jonathan C Irish; Suzanne Kamel-Reid
Journal:  Mol Cancer       Date:  2010-09-10       Impact factor: 27.401

8.  Programmed cell death 4 mechanism of action: The model to be updated?

Authors:  Polina N Vikhreva; Svetlana V Kalinichenko; Igor V Korobko
Journal:  Cell Cycle       Date:  2017-08-30       Impact factor: 4.534

9.  Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells.

Authors:  Shuhong Zhang; Jianfeng Li; Ying Jiang; Yijun Xu; Chengyong Qin
Journal:  J Exp Clin Cancer Res       Date:  2009-05-29

10.  Structures of the Shigella flexneri type 3 secretion system protein MxiC reveal conformational variability amongst homologues.

Authors:  Janet E Deane; Pietro Roversi; Carole King; Steven Johnson; Susan M Lea
Journal:  J Mol Biol       Date:  2008-02-04       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.